Product/Composition:- | Hydrochlorothiazide Tablets |
---|---|
Strength:- | 12.5 mg, 25 mg, 50 mg |
Form:- | Tablet |
Reference Brands:- | Microzide, HydroDiuril(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Hydrochlorothiazide tablets are thiazide diuretics that increase urine output by inhibiting sodium reabsorption in the kidneys. Benefits include lowering blood pressure, reducing edema, and preventing heart failure complications. They help control hypertension, decrease fluid buildup, and promote cardiovascular health by reducing strain on the heart.
Hydrochlorothiazide tablets are approved in both the US and EU, supported by detailed dossiers demonstrating safety, efficacy, and manufacturing quality in accordance with GMP standards. In the US, regulatory oversight is provided by the FDA, while the EU’s EMA oversees approval processes. These dossiers include clinical trial data, stability, and safety profiles. Hydrochlorothiazide is widely prescribed for hypertension and edema management, obtaining market authorization after rigorous evaluation. For comprehensive licensing information, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Stay informed on regulatory requirements and market access pathways for hydrochlorothiazide products globally.